334 related articles for article (PubMed ID: 25436148)
1. Signaling pathways involved in renal oxidative injury: role of the vasoactive peptides and the renal dopaminergic system.
Rukavina Mikusic NL; Kravetz MC; Kouyoumdzian NM; Della Penna SL; Rosón MI; Fernández BE; Choi MR
J Signal Transduct; 2014; 2014():731350. PubMed ID: 25436148
[TBL] [Abstract][Full Text] [Related]
2. Atrial natriuretic peptide and renal dopaminergic system: a positive friendly relationship?
Choi MR; Rukavina Mikusic NL; Kouyoumdzian NM; Kravetz MC; Fernández BE
Biomed Res Int; 2014; 2014():710781. PubMed ID: 25013796
[TBL] [Abstract][Full Text] [Related]
3. Renal dopaminergic system: Pathophysiological implications and clinical perspectives.
Choi MR; Kouyoumdzian NM; Rukavina Mikusic NL; Kravetz MC; Rosón MI; Rodríguez Fermepin M; Fernández BE
World J Nephrol; 2015 May; 4(2):196-212. PubMed ID: 25949933
[TBL] [Abstract][Full Text] [Related]
4. Intrarenal dopamine coordinates the effect of antinatriuretic and natriuretic factors.
Holtbäck U; Kruse MS; Brismar H; Aperia A
Acta Physiol Scand; 2000 Jan; 168(1):215-8. PubMed ID: 10691803
[TBL] [Abstract][Full Text] [Related]
5. Intrarenal dopamine: a key signal in the interactive regulation of sodium metabolism.
Aperia AC
Annu Rev Physiol; 2000; 62():621-47. PubMed ID: 10845105
[TBL] [Abstract][Full Text] [Related]
6. Intrarenal angiotensin II inhibition influences the actions of atrial natriuretic peptide.
Steele TH; Challoner-Hue L
Clin Sci (Lond); 1990 May; 78(5):475-80. PubMed ID: 2162273
[TBL] [Abstract][Full Text] [Related]
7. Renal effects of atrial natriuretic factor during control of the renin-angiotensin system in anesthetized dogs.
Seymour AA; Mazack EK
Circ Res; 1988 Mar; 62(3):506-14. PubMed ID: 2830044
[TBL] [Abstract][Full Text] [Related]
8. Atrial natriuretic hormone, the renin-aldosterone axis, and blood pressure-electrolyte homeostasis.
Laragh JH
N Engl J Med; 1985 Nov; 313(21):1330-40. PubMed ID: 2932646
[TBL] [Abstract][Full Text] [Related]
9. Atrial natriuretic peptide: water and electrolyte homeostasis.
Kenyon CJ; Jardine AG
Baillieres Clin Endocrinol Metab; 1989 Aug; 3(2):431-50. PubMed ID: 2560911
[TBL] [Abstract][Full Text] [Related]
10. Oleanolic acid modulates the renin-angiotensin system and cardiac natriuretic hormone concomitantly with volume and pressure balance in rats.
Ahn YM; Choi YH; Yoon JJ; Lee YJ; Cho KW; Kang DG; Lee HS
Eur J Pharmacol; 2017 Aug; 809():231-241. PubMed ID: 28514645
[TBL] [Abstract][Full Text] [Related]
11. Effects of a dual inhibitor of angiotensin converting enzyme and neutral endopeptidase, MDL 100,240, on endocrine and renal functions in healthy volunteers.
Rousso P; Buclin T; Nussberger J; Décosterd LA; La Roche SD; Brunner-Ferber F; Brunner HR; Biollaz J
J Hypertens; 1999 Mar; 17(3):427-37. PubMed ID: 10100082
[TBL] [Abstract][Full Text] [Related]
12. Protective Renal Effects of Atrial Natriuretic Peptide: Where Are We Now?
Choi MR; Fernández BE
Front Physiol; 2021; 12():680213. PubMed ID: 34135773
[TBL] [Abstract][Full Text] [Related]
13. The interaction between atrial natriuretic peptides and angiotensin II in controlling sodium and water excretion in the rat.
Chamienia AL; Johns EJ
Br J Pharmacol; 1991 Aug; 103(4):1893-8. PubMed ID: 1833019
[TBL] [Abstract][Full Text] [Related]
14. Effect of natriuretic agents, vasoactive agents and of the inhibition of metabolism on sodium handling in the isolated perfused kidney of the nephrotic rat.
Firth JD; Ledingham JG
Clin Sci (Lond); 1990 Dec; 79(6):559-74. PubMed ID: 2176943
[TBL] [Abstract][Full Text] [Related]
15. The renal paracrine peptide system--possible urologic implications of urodilatin.
Meyer M; Stief CG; Becker AJ; Truss MC; Taher A; Jonas U; Forssmann WG
World J Urol; 1996; 14(6):375-9. PubMed ID: 8986039
[TBL] [Abstract][Full Text] [Related]
16. Effects of atrial natriuretic factor on the vasoconstrictor actions of the renin-angiotensin system in conscious rats.
Lappe RW; Todt JA; Wendt RL
Circ Res; 1987 Jul; 61(1):134-40. PubMed ID: 3038365
[TBL] [Abstract][Full Text] [Related]
17. Altered regulation of renal interstitial hydrostatic pressure and the renal renin-angiotensin system in the absence of atrial natriuretic peptide.
O'Tierney PF; Komolova M; Tse MY; Adams MA; Pang SC
J Hypertens; 2008 Feb; 26(2):303-11. PubMed ID: 18192845
[TBL] [Abstract][Full Text] [Related]
18. Natriuretic peptides buffer renin-dependent hypertension.
Demerath T; Staffel J; Schreiber A; Valletta D; Schweda F
Am J Physiol Renal Physiol; 2014 Jun; 306(12):F1489-98. PubMed ID: 24717731
[TBL] [Abstract][Full Text] [Related]
19. Modulation of exogenous and endogenous atrial natriuretic peptide by a receptor inhibitor.
Stevens TL; Wei CM; Aahrus LL; Heublein DM; Kinoshita M; Matsuda Y; Burnett JC
Hypertension; 1994 May; 23(5):613-8. PubMed ID: 8175170
[TBL] [Abstract][Full Text] [Related]
20. Atrial natriuretic factor and the endocrine control of electrolyte homeostasis.
Cogan E
Acta Cardiol; 1991; 46(3):377-84. PubMed ID: 1833942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
